Real-time enrollment status for this generalized anxiety disorder clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 7:02 AM UTC
| NCT Number | NCT06701903 |
| Recruiting Status | Recruiting |
| Condition | Generalized Anxiety Disorder |
| Phase | PHASE2 |
| Target Enrollment | 570 participants |
| Active Locations | 25 sites in the US |
| Sponsor | Intra-Cellular Therapies, Inc. |
| Last Updated on CT.gov | August 31, 2026 (Yesterday) |
As of September 1, 2026: Clinical trial NCT06701903 is currently recruiting participants. This phase2 study for generalized anxiety disorder is actively seeking new participants at 25 locations across the United States. The study is sponsored by Intra-Cellular Therapies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06701903 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 25 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06701903 was last updated Yesterday (August 31, 2026). HelloStudys verifies this status automatically.